Position
Chief Scientific Officer
Company
Nilogen Oncosystems
Description
Nilogen Oncosystems, a privately-held biotechnology company dedicated to increasing efficiency and reducing risk in the oncology drug development process, has announced the appointment of its Vice President of Research and Operations, Rikhia Chakraborty, Ph.D., to Chief Scientific Officer. As Chief Scientific Officer, Dr. Chakraborty will handle internal and external communication to aid in the expansion of Nilogen Oncosystems' mission to significantly improve the rate of success for novel oncology therapies in the clinic by utilizing Nilogen's proprietary 3D models of patients' tumors to perform complex immuno-oncology studies. Dr. Chakraborty's appointment comes after the sudden passing of Dr
Other recent leadership changes in Biotechnology and Health Care
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Aitia Appoints Drug R&D Executive Jean-Michel Gries as President & Chief Operating Officer (September 19, 2023)
- Nostics Appoints Medtech Leader Jeroen Nieuwenhuis as CEO (September 19, 2023)
- Rezo Therapeutics Appoints Nadir Mahmood, Ph.D., as Chief Executive Officer (September 20, 2023)
- Pison Technology Appoints Industry Experts to C-Suite, Prepares to Address New Markets (September 26, 2023)
- Prospection Appoints Technology-industry Veteran and Commercialization Leader Daniel West to Chief Executive Officer (September 26, 2023)
- Implicity Expands Senior Leadership Team with New U.S. Chief Commercial Officer (September 27, 2023)
Who to call at Nilogen Oncosystems, and when
A new leader at Nilogen Oncosystems brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Nilogen Oncosystems raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Nilogen Oncosystems, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Nilogen Oncosystems. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Nilogen Oncosystems changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Nilogen Oncosystems changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.